BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28903040)

  • 1. miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb.
    Chen Z; Stelekati E; Kurachi M; Yu S; Cai Z; Manne S; Khan O; Yang X; Wherry EJ
    Cell Rep; 2017 Sep; 20(11):2584-2597. PubMed ID: 28903040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor c-Myb regulates CD8
    Gautam S; Fioravanti J; Zhu W; Le Gall JB; Brohawn P; Lacey NE; Hu J; Hocker JD; Hawk NV; Kapoor V; Telford WG; Gurusamy D; Yu Z; Bhandoola A; Xue HH; Roychoudhuri R; Higgs BW; Restifo NP; Bender TP; Ji Y; Gattinoni L
    Nat Immunol; 2019 Mar; 20(3):337-349. PubMed ID: 30778251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-150-Mediated Foxo1 Regulation Programs CD8
    Ban YH; Oh SC; Seo SH; Kim SM; Choi IP; Greenberg PD; Chang J; Kim TD; Ha SJ
    Cell Rep; 2017 Sep; 20(11):2598-2611. PubMed ID: 28903041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-150 Regulates Differentiation and Cytolytic Effector Function in CD8+ T cells.
    Smith NL; Wissink EM; Grimson A; Rudd BD
    Sci Rep; 2015 Nov; 5():16399. PubMed ID: 26549197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15R.
    Ye Z; Shi M; Xu S; Xiang J
    Mol Immunol; 2010 Aug; 47(14):2411-21. PubMed ID: 20569988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical functions for c-Myb at three checkpoints during thymocyte development.
    Bender TP; Kremer CS; Kraus M; Buch T; Rajewsky K
    Nat Immunol; 2004 Jul; 5(7):721-9. PubMed ID: 15195090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myb regulates transcriptional activation of miR-143/145 in vascular smooth muscle cells.
    Chandy M; Ishida M; Shikatani EA; El-Mounayri O; Park LC; Afroze T; Wang T; Marsden PA; Husain M
    PLoS One; 2018; 13(8):e0202778. PubMed ID: 30169548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-15/16 Antagonizes Myb To Control NK Cell Maturation.
    Sullivan RP; Leong JW; Schneider SE; Ireland AR; Berrien-Elliott MM; Singh A; Schappe T; Jewell BA; Sexl V; Fehniger TA
    J Immunol; 2015 Sep; 195(6):2806-17. PubMed ID: 26268657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
    D'Aguanno S; Valentini E; Tupone MG; Desideri M; Di Martile M; Spagnuolo M; Buglioni S; Ercolani C; Falcone I; De Dominici M; Milella M; Rizzo MG; Calabretta B; Cota C; Anichini A; Trisciuoglio D; Del Bufalo D
    J Exp Clin Cancer Res; 2018 Nov; 37(1):278. PubMed ID: 30454024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-140-3p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Peripheral Artery Disease.
    Zhu ZR; He Q; Wu WB; Chang GQ; Yao C; Zhao Y; Wang M; Wang SM
    J Atheroscler Thromb; 2018 Nov; 25(11):1168-1181. PubMed ID: 29760303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected positive control of NFκB and miR-155 by DGKα and ζ ensures effector and memory CD8+ T cell differentiation.
    Yang J; Zhang P; Krishna S; Wang J; Lin X; Huang H; Xie D; Gorentla B; Huang R; Gao J; Li QJ; Zhong XP
    Oncotarget; 2016 Jun; 7(23):33744-64. PubMed ID: 27014906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.
    Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R
    Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8
    Guan T; Dominguez CX; Amezquita RA; Laidlaw BJ; Cheng J; Henao-Mejia J; Williams A; Flavell RA; Lu J; Kaech SM
    J Exp Med; 2018 Apr; 215(4):1153-1168. PubMed ID: 29449309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.
    Xiao C; Calado DP; Galler G; Thai TH; Patterson HC; Wang J; Rajewsky N; Bender TP; Rajewsky K
    Cell; 2007 Oct; 131(1):146-59. PubMed ID: 17923094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling.
    Gracias DT; Stelekati E; Hope JL; Boesteanu AC; Doering TA; Norton J; Mueller YM; Fraietta JA; Wherry EJ; Turner M; Katsikis PD
    Nat Immunol; 2013 Jun; 14(6):593-602. PubMed ID: 23603793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation.
    Wu T; Wieland A; Araki K; Davis CW; Ye L; Hale JS; Ahmed R
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9965-70. PubMed ID: 22665768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.
    Petschner F; Zimmerman C; Strasser A; Grillot D; Nunez G; Pircher H
    Eur J Immunol; 1998 Feb; 28(2):560-9. PubMed ID: 9521066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development.
    Lin YC; Kuo MW; Yu J; Kuo HH; Lin RJ; Lo WL; Yu AL
    Mol Biol Evol; 2008 Oct; 25(10):2189-98. PubMed ID: 18667440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells.
    Ichii H; Sakamoto A; Hatano M; Okada S; Toyama H; Taki S; Arima M; Kuroda Y; Tokuhisa T
    Nat Immunol; 2002 Jun; 3(6):558-63. PubMed ID: 12021781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.